All industry news
RegulationApril 30, 2026

enVVeno Medical secures FDA IDE approval for venous valve study

enVVeno Medical received FDA Investigational Device Exemption (IDE) approval to proceed with a pivotal clinical study of its non-surgical venous valve replacement device. IDE approval permits the company to begin human testing as part of the pathway toward broader regulatory clearance.

The source

This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.

Read the full story at Medical Device Network
MedIndexer aggregates and summarises publicly available headlines. Full article text remains the property of the originating publication.